Acellular matrices derived from animal and human cadaveric donor vessels or other tubular matrices are appropriate candidates for the creation of tissue-engineered, small-diameter, muscular arteries. Engineering principles have been used to design a bioreactor and the necessary auxiliary systems for the reconstitution of a previously decellularized vascular matrix. The bioreactor enables the attachment of cells to the luminal and/or exterior surfaces of the matrix. For the recellularization procedure, the matrix is situated within a sealed compartment in order to maintain a sterile environment. The matrix is rotated continuously to assure a spatially uniform reconstitution. The auxiliary systems that serve the bioreactor are: (a) an oxygenator, (b) peristaltic pumps, one for conveying the internal cell medium and the other for conveying the external cell medium, (c) motor and gearing to create steady and controlled rotation, (d) reservoirs for the containment of the two media, and (e) tubing to convey the respective fluids and to interconnect the bioreactor culture chamber to the various auxiliary components. A recellularized matrix produced by the bioreactor demonstrated its capabilities to reconstitute a previously decellularized scaffold.
INTRODUCTION
There is currently significant interest in creating human vasculature by making use of scaffolds taken from decellularized vessels or other tubular matrices [1] . One attractive feature of this tissue engineering approach is that those matrices can be harvested from animal and human donors and recellularized with host-specific (autologous) cells. Harvesting appropriate cells from a patient, expanding the cells in culture, and applying them to the decellularized matrix, accomplish recellularization.
This interest has motivated innovative procedures both for decellularization and for reconstitution of the matrix with cells. In this paper, the design and implementation of a device for reconstitution is described. The capabilities of the device have been verified by laboratory experiments. This device will be termed the Internal and External Flow Bioreactor. The bioreactor facilitates the reconstitution process on both the inner and outer surfaces of the vascular matrix. In particular, the utilization of the device provides a coating of cells on the inner surface of the decellularized tubular matrix constructs-no matter the origin. To complete the production of replacement vessels requires an additional step in which smooth muscle cells (SMCs) are added to obtain a co-cultured arterialized construct. This task is also accomplished by the bioreactor described here.
The engineering of small-diameter artificial arteries in-vitro has recently been reviewed [1] . That review reveals a variety of methodologies for tissue-engineered arterial replacements in various stages of development. In the present paper, attention is focused on the use of decellularized vascular or tubular matrices as scaffolds to which cells may be attached. The literature contains a number of papers [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] that deal with various issues related to recellularization of decellularized vascular matrices, but it appears that a goal-oriented, firstprinciples-engineered, operation-proven device to perform recellularization has not been created. As discussed in the preceding paragraph, the goal of the present work is to design, fabricate, and validate the efficacy of such a device. which would enable a continuous flow of tissue-culture medium both within the lumen of the decellularized matrix and over its external surface. That vision also included the idea of matrix rotation to ensure the spatial uniformity of the final cellular deposition. The minimum requirements that were specified at the initiation of the design process included: a) Continuous, automated, and low-RPM matrix rotation; b) Closed-loop, operator-controlled perfusion of both the lumen and the external surface of the vascular matrix; c) Leakage-free interfaces which enforce the maintenance of a sterile environment within the processing chamber; d) Sterilizability of device components that interact with biological products.
The need for Requirement A is to increase the likelihood of confluent distribution of the endothelial cells (ECs) in the lumen and smooth muscle cells on the outer surface of the vascular matrix. Requirement B was motivated by the desire to separate and separately control perfusion of the interior and exterior of the matrix to fulfill the goal of depositing potentially different cell types on the interior and exterior surfaces in recognition of different biological needs. Requirements C and D, taken together, provide for the sterility of the culture environment.
DEVICE OVERVIEW
The description of the device will be subdivided into two main sections. The first will convey a schematic of the overall system; describe its functionality, and its mode of operation. Subsequently, a number of photographs will be displayed to illustrate the practical implementation of the device.
The device schematic is displayed in Figure 1 . The figure is a schematic flow diagram of the internal and external flow bioreactor. The heart of the device is the bioreactor culture chamber. It is a cylindrical vessel having a diameter and length of about 25mm and 75 mm, respectively, with its axis horizontal. It is made of transparent polycarbonate. The function of the culture chamber is to provide a sterile environment in which a decellularized tubular matrix is supported at its ends. The matrix is separately perfused both internally and externally. Internal perfusion is accomplished by connecting the respective ends of the matrix to the cell-culture-medium supply and extraction ports that are respectively located at either end of the bioreactor. External perfusion is accomplished via ports into and out of the bioreactor culture chamber.
It can be seen from the figure that the two flow circuits are independent and have their own auxiliaries. One of the auxiliaries is an autoclavable cell-culture flask that is sealed by a rubber stopper equipped with inlet and outlet ports. A second is a peristaltic pump that is situated downstream of the flask. The pump is able to provide flow-rates between 0.06 mL/min and 43 mL/min. The discharge of the pump is delivered to the pressurized oxygenator, the third auxiliary, whose function is to maintain the oxygen content to replace that lost in cellular respiration.
A key feature of the bioreactor is the capability to rotate the vascular matrix simultaneously with its perfusion. The RPM of the rotation is adjustable from one to three revolutions per minute. The rotational components include not only the vascular matrix, but also the matrix support members to which the matrix is attached. Rotation is achieved by means of a low-RPM DC motor. The external shell of the bioreactor does not rotate. Figure 2 illustrates the key components of the device. As can be seen in the figure, the underlying structure of the device is made of a plastic, and Delrin was chosen because of machinability and autoclavability. The bioreactor culture chamber is seen to be the central feature of the device. Provision was allowed in the structure for a drive shaft which extended from the proximal and distal ends of the device. The shaft was driven by a motor situated at the distal end. By means of a pair of gears which mate with the driveshaft, rotation is imparted to the matrix and its supporting structures. The entire assembly is laid out on a 6.25-mm-thick aluminum plate. Figure 3 is a downward-directed view of the fabricated device in its operational environment. The setup of the device is specific to the perfusion of the lumen. Therefore, the exhibited components relate to that mode 
DEVICE DETAILS
The design of the bioreactor includes a number of features that guarantee its proper operation. These design details will now be displayed. A dissassembled view of the bioreactor and its components is presented in Figure 5 . Shown there are the parts of the parent syringes that were utilized for the support of the matrix and for the delivery and extraction for the perfusing fluid. The matrix support structure is seen to consist of a barrel-like disc at either end and a bridging structure that interconnects them. A critical issue was the attainment of a leak-free seal between the matrix support structure and the inner surface of the bioreactor culture vessel. The seal was accomplished by the use of O-rings set into suitible-dimensioned grooves.
The matrix support members are highlighted in Figure 6 . Each member consists of the delivery end of a syringe enhanced by a trio of O-rings to obtain a leak-free seal at the interface of the support members and the culture chamber. Provision was made, by means of a knurled handle, for compressing the O-rings to the appropriate sealing pressure. The funnel-like plastic pieces that convey and extract the perfusing fluid are also cleary shown.
The sleeve interconnect provides the rigidity needed for stability during the attachment of the vascular matrix to the support structure and subsequent insertion of the loaded matrix into the polycarbonate cylinder. The vascular matrix support member is the needle component of a luer-lock syringe.
The last of the detail figures is Figure 7 . This figure is focused on displaying the components that comprise the inflow end of the system. Shown there is the drive mechanism which includes the drive shaft, the vascular matrix rotation gear, the idler shaft, and the fluid delivery path. The fluid passes from right to left through a fluid coupling clamp and the rotating fluid coupling.
APPARATUS ASSEMBLY AND OPER-ATING PROTOCOL

Assembly of the Bioreactor
The first step in the assembly of the bioreactor is described by making reference to Figure 5 . The gap be- tween the vascular matrix support members is bridged by the matrix which is sutured in place. The positioning of the matrix is defined so that the suture is situated just upstream of the flaired polyethylene fitting displayed in Figure 6 . The next step also makes use of Figure 5 . The O-rings displayed in the foreground of the figure are put in place in the vascular matrix support member reinforcement sleeve. Then, the bioreactor culture chamber is forced over the O-rings to create an air-tight seal. This sub-assembly is mated to the gear-ensleeved rotating fluid coupling that is called out in Figure 7 . Prior to the mating, a bolus of cells must be injected to line the interior of the matrix by means of a syringe. The injection is accomplished here through the ports that are called out in Figure 5 . At this point, the Delrin blocks, visible in the foreground of Figure 7 , are adjusted so that the idler gear mates perfectly with the driving gear. Next, the gearensleeved rotating fluid coupling is inserted into the adjustable clamp that is called out in Figure 7 . Then, the various connections to facilitate the management of the flowing media are made. These connections can be seen in Figure 1 .
Operating Protocol
There are a number of operating protocols that may be used to achieve different objectives. These include: (a) uniform coating of the interior surface of the decellularized vascular matrix with endothelial cells, (b) uniform coating of the exterior of the vascular matrix with smooth muscle cells or other cells, and (c) reconstitution of both matrix surfaces with their respective native cell lines. The description of the operating protocol for the latter will be conveyed here, since it is the most encompassing. To begin the description, it is to be noted that the interior of the vascular matrix has already received a bolus of endothelial cells. Then, the rotation of the matrix is initiated and, simultaneously, an endothelial cell culture medium is circulated about the outside of the vascular matrix to provide diffusion-mediated nourishment for the adhering layer of the endothelial cells on the interior surface of the matrix. The nourishment phase is continued for about eight hours and then discontinued. At this point, a large suspension of smooth muscle cells is injected into the culture vessel which is filled to a height that envelops the vascular matrix. Simultaneously, the nourishment stream that formerly passed over the outer surface of the matrix is now ducted to flow through the lumen of the matrix. These conditions are continued for a period of approximately 12 hours. Then, a slightly different arrangement is initiated. While the nourishment stream passing through the lumen is continued, a second stream consisting of smooth muscle cell culture medium is passed through the culture vessel as a continuous flow.
To decide on a stopping point of these operations, it is necessary to weigh the probability of a more confluently reconstituted interior and exterior matrix against the probability of compromising sterility. From experience with various methods of matrix reconstitution, a period on the order of three to four days should be allowed prior to the stoppage of matrix perfusion and rotation. Prior to the stoppage, preparations have to be made for histologic analysis of the reconstituted matrix.
HISTOLOGIC ANALYSIS OF THE RECONSTITUTED MATRIX
The sought-for information from the histologic analysis is the uniformity of the cell coverage and evidence that recellularization is achieved on both interior and exterior surfaces of the reconstituted matrix. To convey this information, a representative sample of fluorescently stained histologic images is presented in Figures 8, 9 , 10 and 11. 
CONCLUDING REMARKS
The key functional features of the device designed and implemented here are the following: taneous intra-lumenal and extra-lumenal perfusion Leakage-free interfaces which favor the maintenance of a sterile environment within the bioreactor culture chamber  Autoclavability of all device components that interact with the culture medium  Autoclavability of every device component except the motor  Custom-designed, high-capacity oxygenator  Three degrees of freedom to adjust for vessels of different lengths  Easy operator access to vascular matrix installation and removal  Positive anchoring of vascular matrix A laboratory application of the device confirmed the capability of the Internal and External Flow Bioreactor to recellularize previously decellularized matrices of biological origin. In conclusion, this apparatus enables a more standardized approach for the recellularization of decellularized matrices and in doing so, expands investigative opportunities in the area of tissue-engineered blood vessels. 
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